Download and complete the Enrollment and Prescription Form and fax to: 855-423-0011
Strongly recommended by AAD as a systemic therapy for moderate-to-severe atopic dermatitis in adult patients1
//
SAVINGS & SUPPORT
Help your patients get the comprehensive support they need to start and stay on track with treatment
Personalized treatment support for your eligible patients starts here*
Or, choose one of the following enrollment options:
The Adbry® Advocate™ Program provides a range of support services for patients who qualify.
LEO Pharma is committed to helping ensure that patients can access and initiate therapy when prescribed Adbry, including through the Adbry® Advocate™ Program. Restrictions apply.
See Full Terms, Conditions, and Eligibility Rules. For eligible patients, the Program consists of:
Adbry® Rapid Access™ Program
Our goal is for your eligible patients to receive their first dose of Adbry® for free within approximately 48 hoursa,b,c
Adbry® Bridge Care™ Program
Eligible, commercially insured patients whose insurance does not yet cover Adbry® provides for a maximum of six (6) months of shipment of Product, on a periodic basis, within a twenty-four (24) month consecutive time period commencing on the initial date of dispense for such patient’s lifetime, or until such patient receives insurance coverage approval, whichever occurs earlierb,c
Adbry® Copay Program
With the Adbry® Copay Program, eligible, commercially insured patients may pay as little as a $0 copay per fill of Adbryb,c
Adbry® Patient Assistance Program
Eligible patients with demonstrated financial need and with limited or no prescription coverage may be able to receive Adbry at no cost via the Adbry® Patient Assistance Programb,d
Patient Access Support Kit
Suggested best practices and letter templates for appealing denials of prior authorizations
aThe initial dose of Adbry may be shipped either to your office or to the patient after submission of a completed Enrollment and Prescription Form or annual Healthcare Provider eRx Program Certification Form, as applicable, and Patient Authorization. A program representative will coordinate shipment to a patient, which may extend delivery time. Patients who have been initiated on therapy with samples are not eligible for Rapid Access Product.
bAdditional terms, conditions, and eligibility rules apply. Enrollment in Adbry Advocate is not required to obtain copay support. For all other patient support programs, enrollment in Adbry Advocate is required. Patient or healthcare provider may not seek reimbursement for the benefit received from any party. LEO Pharma reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.
cPatient is not eligible for the Program if enrolled in any federally or state funded health care program, including but not limited to Medicare (including Medicare Part D), Medicaid, VA, DOD, TRICARE or CHIP.
dIncome eligibility requirements apply. Patient may be required to submit documentation of income and insurance coverage status.
*Program has an annual cap. Program may not be combined with any third-party rebate, coupon or offer.
Downloadable Resources
Videos
MOA Video
Actor portrayal.
Adbry Autoinjector Administration for Adults
Adbry Prefilled Syringe Administration for Adults
Adbry Administration for Children 12 Years and Older
//
ASSESSMENT SCALES
EASI, IGA, and Pruritus NRS Scales
Example representation of IGA scoring. Not an actual patient.
The NRS is composed of one item and represents the numbers 0 (“no itch”) to 10 (“worst imaginable itch”). Subjects are asked to rate the intensity of their itch using this scale.
